Tune Therapeutics
PrivateLast Round
Series B
Jan 13, 2025
Total Funding Raised
$215M
Momentum Score
25 /100
Company Overview
Tune Therapeutics is a biotechnology company that specializes in an epigenetic programming platform aimed at developing innovative cell and gene therapies for the treatment of complex diseases by reprogramming biology through the epigenome without modifying the DNA sequence.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B2C
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tune Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Tune Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 13, 2025 | ||||
| Series A | Dec 2, 2021 |
Key People
Founding team and executive leadership
Tune Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Enterprise Associates (NEA) | Series A, Series B |
| Duke Capital Partners | Series A, Series B |
| Hatteras Venture Partners | Series A |
| Hevolution Foundation | Series B |
| Yosemite | Series B |
| Emerson Collective | Series A |
| Mission BioCapital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2025
Dr. John McHutchison appointed as new Chief Executive Officer.
- Jan 22, 2025
Attended and showcased advancements at the JPM 2025 conference.
Tune Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tune Therapeutics's valuation, stock price, and market status.
